United Therapeutics to report Q2 2026 results on August 5
United Therapeutics Corporation will release its Q2 2026 financial results on August 5, 2026, at 6:30 a.m. ET, followed by a webcast at 9:00 a.m. ET. The webcast will be accessible online, with a rebroadcast available for one year.
*this image is generated using AI for illustrative purposes only.
United Therapeutics Corporation (Nasdaq: UTHR) will announce its second quarter 2026 financial results on Wednesday, August 5, 2026, at approximately 6:30 a.m. Eastern Time. The announcement will be made via a press release, providing investors with an update on the company's performance for the quarter.
Following the release, United Therapeutics will host a public webcast at 9:00 a.m. Eastern Time on the same day. The webcast will be accessible at https://ir.unither.com/events-and-presentations . A rebroadcast of the webcast will be available for one year at the same location.
Key Event Details
| Event | Date | Time (ET) |
|---|---|---|
| Q2 2026 Financial Results Release | August 5, 2026 | 6:30 a.m. |
| Investor Webcast | August 5, 2026 | 9:00 a.m. |
United Therapeutics focuses on transforming the treatment of rare diseases and pioneering alternatives to expand the supply of transplantable organs. The company operates as a public benefit corporation, emphasizing patient service, integrity, and sustainable practices.
Investors and interested parties can access the webcast and subsequent rebroadcast through the company's investor relations website. The announcement marks a scheduled update in the company's financial calendar.
What key performance indicators will investors focus on during the Q2 2026 earnings call?
How might United Therapeutics' advancements in organ transplantation impact its financial outlook?
What are the expected market reactions to the Q2 2026 results announcement?
16
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
